542.00INR -7.10 ( -1.29%) VOLUME : 74000
    Average Volume
  • 5-Day 35,600.00
  • 20-Day 42,650.00
  • 3-Months 39,961.54


Price Table

Date Open High GREEN: if High is higher than last 2 days high
RED: if high is lower than last 2 days high
Low GREEN:if Low is higher than last 2 days low
RED: if low is lower than last 2 days low
LTP Close GREEN:if Day's Closing is near the Day's High
RED: if low is lower than last 2 days low
Volume Delivery % 20 Day SMA GREEN: if Day's Closing is above 20-Day SMA
RED: if Day's Closing is below 20-Day SMA
50 Day SMA GREEN: if Day's Closing is above 50-Day SMA
RED: if Day's Closing is below 50-Day SMA
100 Day SMA GREEN: if Day's Closing is above 100-Day SMA
RED: if Day's Closing is below 100-Day SMA
200 Day SMA GREEN: if Day's Closing is above 200-Day SMA
RED: if Day's Closing is below 200-Day SMA
18-Oct-19 550.00 565.00 535.00 542.00 544.00 73,661 50% 529.72 517.01 515.92 535.69
17-Oct-19 524.20 552.90 522.50 552.90 549.10 35,149 68% 528.55 516.56 515.73 535.83
16-Oct-19 527.80 535.95 520.50 525.00 522.80 25,681 75% 525.84 516.06 515.51 535.98
15-Oct-19 532.40 539.90 524.25 530.00 528.30 30,995 69% 524.96 515.69 515.58 536.36
14-Oct-19 540.00 548.00 532.00 534.00 535.45 12,152 69% 523.95 515.73 515.58 536.71
11-Oct-19 540.50 551.00 531.10 551.00 545.70 58,529 93% 522.71 515.73 515.49 537.03
10-Oct-19 537.30 547.80 531.80 537.65 540.10 29,907 81% 520.61 515.56 515.34 537.32


Key Data

Day High Low Range

Time Lowest Highest
10 AM 542.00 565.00
11 AM 542.00 565.00
12 PM 542.00 565.00
1 PM 542.00 565.00
2 PM 542.00 565.00

Company Profile - APLLTD Ltd.


APLLTD or Alembic Pharmaceuticals Limited was established in 1907 is India’s leading pharmaceutical company. Also, the company is vertically integrated, along with the ability to manufacture, develop, and market pharmaceutical products, and pharmaceutical substances and the intermediates. Also, it is the market leader in the Macrolides section of anti-infective drugs in the country. The Alembic Pharmaceuticals have presented an extensive spectrum of both branded and generic formulations, along with the international and national regulations. Its manufacturing facilities are also located in Vadodara and Baddi in the state Himachal Pradesh. The plant situated at Vadodara has the largest fermentation capacity in the country. And the Panelav facility has the API and formulation manufacturing (both of them US FDA approved) plants. The plant located at Baddi, Himachal Pradesh also manufactures the formulations for both the domestic as well as a non-regulat ... ed export market. It has a state of the art Research Centre, which is located at Vadodara. Also, API's make up the most significant part of the operations for the company. It also has an exclusive facility for the manufacturing of synthetic APIs, also consisting of some independent manufacturing blocks for NSAIDs, Macrolides, and other drugs. The API manufacturing facility at panelav has also successfully undergone the inspection of both USFDA and EDQM. It makes the products of Musculoskeletal, Anti Infectives, Cardio Vascular, Erectile Dysfunction, and the Gastro–Intestinal. An independent facility also supports the synthetic BPC business of the company. This specific facility has its type of independent quality control as well as, Analytical Development facility. It is equipped with some of the excellent pilot facility to scale-up, as this specific facility is already working with the leading firms by supplying some critical intermediates for their pipeline products. Also, its extensive range of the finished dosage formulations covers each aspect of human life. Its basket of several formulations contains more than 150+ products in several forms that belong to different therapeutic sections from oral antidiabetics, anti-infective, cough & cold products to cardiovascular. Its domestic formulation products consist of Antibiotics & Antibacterial, Cough & Cold Cardiovascular, Antihistamines, Gynecological, Ortho, Gastrointestinal, Anti Diabetic, Ophthalmological, and Urology. The company also is in the Nutraceuticals business for the last 50 years, and it is spread in 75+ countries. The Company is also one of the robust and integrated pharmaceutical companies across the world. Its international network also drives its mission for providing access to the best healthcare goods at reasonable prices to most of the people in remote countries.

Some of the Group companies:

  • Alembic Limited
  • Year Glass
  • Shreno Ltd.
  • Paushak Ltd.
  • Alchemy Real Estate

Some of the Milestones:

  • 1907 – It started manufacturing tinctures and alcohol at the plant in Vadodara.
  • 1940 – It started manufacturing cough syrup, tonics, vitamins, and sulfur drugs.
  • 1961 – Lal Bahadur Shastri inaugurated the Penicillin plant in 1961.
  • 1967 – The setup of bulk manufacturing of the nutrient, Vitamin B12.
  • 1971 – For the first time, Erythromycin was being manufactured in India.
  • 1972 – Althrocin, which is a brand of Erythromycin, was introduced.
  • 1997 –Althrocin became one of the bestselling brands in India.
  • 1999 – The Company started the production of synthetic organic API.
  • 2000– The Company gets ISO 14000 certification for its facilities located at Vadodara.
  • 2001 – It also started its manufacturing of the Cephalosporin C.
  • 2007 – The acquisition of the non-oncology business of Dabur Pharma Ltd.
  • 2009 – The Company addressed chronic therapies via multiple marketing divisions.
  • 2010 – The ANDA’s total filed 38. And DMF total filed to 53 and got the approval for 15.
  • 2013 – The Company received the approval from the USFDA for its NDA, Desvenlafaxine Base Extended Release (or ER) Tablets.